- After a randomized trial showed no clinical benefit of mitral valve repair among patients with chronic, moderate ischemic MR undergoing coronary artery bypass grafting, the LOE was changed from C (consensus) to B-R (moderate quality evidence from ≥1 randomized controlled trial [RCT] or meta-analyses of moderate-quality RCT) for the Class IIb recommendation for mitral valve repair in this population.
.http://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/03/14/18/26/2017-aha-acc-focused-update-of-valvular-heart-disease
É emocionante ouvir um cirurgião cardíaco descrever o reparo da valva Mitral .
Parece mágico.
Mas não é.
.
Curtir isso:
Curtir Carregando...